F7872/V
FORM - 2
THE PATENTS ACT, 1970
(39 of 1970)
&
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See Section 10 and Rule 13)
PACKAGED OXIDATION-STABLE OIL-IN-WATER EMULSION
HINDUSTAN UNILEVER LIMITED, a company incorporated under the Indian Companies Act, 1913 and having its registered office at Hindustan Lever House, 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India
The following specification particularly describes the invention and the manner in which it is to be performed

07-02-2008 EP20060101
PACKAGED OXIDATION-STABLE OIL-IN-WATER EMULSION
TECHNICAL FIELD OF THE INVENTION
The present invention relates to a packaged oxidation-stable oil-in-water emulsion containing from 0.1-10 wt.% of oil, said oil containing 0.3-80 g of polyunsaturated fatty acids per liter of emulsion. Another aspect of the invention concerns a method for the manufacture of such a packaged oil-in-water
emulsion.
BACKGROUND OF THE INVENTION
It is well-known in the art of food chemistry that the
application of oils containing high levels of polyunsaturated fatty acids can give rise to serious off-flavour problems. These off-flavour problems are associated with the oxidation of the polyunsaturated fatty acids, leading to the formation of volatile, potent, flavour molecules, such as unsaturated
aldehydes. Flavour attributes associated with oxidation products of polyunsaturated fatty acids include "fish", "cardboard", "paint", "oily", "rancid" and "metallic".
It is also known that iron cations even at low concentration of 25 e.g. 0.1 mg /kg behave as strong pro-oxidants. Hence, products containing appreciable amounts of polyunsaturated fatty acids in combination with significant concentrations of iron cations will very quickly develop a strong off-flavour.
formulations containing poly-unsaturated_ fatty acids and
oxidative cations are known for enteral feeding for patients.
eived at the EPO on Feb 07, 2008 11:50:12..
AMENDED SHEET

07:02:2008 UNILEUER PATENT DEPT EP200601012

under the tradename Fresubin energy (Fresenius Kabi AG, Germany).
It is further known that oxidation of polyunsaturated fatty 5 acids may be inhibited through the addition of anti-oxidants. Examples of suitable anti-oxidants include tocopherols, extracts of rosemary, ascorbyl palmitate, citric acid, ascorbic acid, TBHQ, BHA and BHT.
The oxidation of polyunsaturated fatty acids can also be
prevented by ensuring that no oxygen is present in the product in which the polyunsaturated fatty acids are incorporated. This may be achieved by producing such a product under an oxygen-free atmosphere {e.g. nitrogen) and/or by packaging the product
in a package with an oxygen-free headspace or no headspace at all (e.g. Tetra Pak ®).
Production under oxygen-free atmosphere requires sophisticated equipment. Furthermore, the use of oxygen-free atmosphere does
not adequately address the problem of oxidation of
polyunsaturated fatty acids. Commercially available oils that are rich in polyunsaturated fatty acids always contain a certain level of oxidised polyunsaturated fatty acids in the form of peroxides. These peroxides are non-volatile and as such
do not affect the flavour of a product. However, during
processing and storage, these peroxides will degrade to potent flavour molecules, even in the absence of oxygen. In particular in the presence of pro-oxidants, such a iron and cupper cations, the degradation of these peroxides to aldehydes and
other flavour molecules will proceed at a very high rate.
Elevated storage temperatures also accelerate the degradation of these peroxides.
ceived at the EPO on Feb 07, 2008 11:50:12.
AMENDED SHEET,

UNILEVER PATENT DEPT EP20060T0:
SUMMARY OF THE INVENTION
The present inventors have developed a packaged oxidation-stable oil-in-water emulsion comprising an oil with a high content of polyunsaturated fatty acids in combination with a
eived at the EPO on Feb 07, 2008 11:50:12. AMENDED SHEET

07:02:2008 UNILEUER PATENT DEPT EP2006010

substantial amount of pro-oxidative metal cations. Pro-oxidative metal cations such as iron and zinc cations are advantageously incorporated in the present product to provide these essential minerals in amounts that represent a 5 substantial fraction of the recommended daily amount (RDA). The present packaged emulsion offers the advantage that despite the presence of high levels of polyunsaturated fatty acids and appreciable amounts of pro-oxidative metal cations, it does not exhibit off-flavour defects resulting from oxidative
degradation of the polyunsaturated fatty acids. As a matter of fact, the present packaged emulsion can be stored for up to several months under tropical conditions without any significant off-flavour development.
The inventors have found that oxidation of polyunsaturated fatty acids in an emulsion that additionally contains pro-oxidative metal cations, can effectively be prevented, even if the emulsion is produced under conditions in which it is in direct contact with air, if the emulsion is packaged in a
container that holds no headspace and if a very high
concentration of vitamin C is incorporated in the emulsion.
DETAILED DESCRIPTION OF THE INVENTION
Accordingly, one aspect of the invention relates to a packaged, oxidation-stable oil-in-water emulsion comprising:
• 0.1-10 wt.& of oil, said oil containing 0.3-80 g of
polyunsaturated fatty acids per liter of emulsion;
• at least -3r20 mg/1 of p-re—oxidative metaliron cations; 10-2000 mg/1 of vitamin C; and
• up to 98 wt.% of water;
wherein the container comprising the emulsion holds no headspace and wherein the molar ratio of vitamin C to pro-
iceived at the EPO on Feb 07, 2008 11:50:12. AMENDED SHEET
074*200 UNILEVER PATENT DEPT EP20060101
oxidative metal cations exceeds 1:2, and wherein the emulsion
contains at least 10 mg/1 of polyunsaturated fatty acids selected from the group consisting of docosahoxenoic £?cid (DHA), eicosapentenoic acid (EPA) and combinations
thereof.
The terminology "packaged emulsion" as used herein refers to a combination of an emulsion and a container holding said 10 emulsion. The container holding the present emulsion can be any container that can be filled with the present emulsion in such a way that no headspace remains in the container. A particularly preferred container is a so called Tetra Pak ©.
The term "headspace" as used herein refers to the gaseous contents of a filled container. The terminology "holds no headspace" implies that the container holds essentially no headspace. Preferably, headspace represents less than 0.1 vol.%, more preferably less than 0.01 vol.% of the internal
volume of the container. Most preferably, headspace represents vol.% of the internal volume of the container.
The term "oil" as used herein refers to a lipid material,
preferably to a lipid material that is liquid at 30°C, more preferably at 20°C. Examples of lipid materials include
triglycerides, diglycerides, monoglycerides and phospholipids.
Most preferably, the oil is a triglyceride oil. According to a
particularly preferred embodiment, the present emulsion contain
at least 0.5 wt.% of oil.
The term "polyunsaturated fatty acids" as used herein refers to C12-C24 fatty acids comprising two or more double bonds. The polyunsaturated fatty acids may be present in the form of free

ceived at the EPO on Feb 07, 2008 11:50:12. AMENDED SHEET

fatty acids and/or as fatty acid residues, e.g. in the form of fatty acid esters of glycerol. Preferably, the polyunsaturated fatty acids are contained in triglycerides. The concentration of polyunsaturated fatty acids in the present emulsion advantageously exceeds 0.5 g/1.

WO 2007/054195

PCT/EP2006/01014


The pro-oxidative metal cations present in the packaged emulsion are selected from the group consisting of iron cations, copper cations, zinc cations and combinations thereof. 5 More preferably, the pro-oxidative metal cations are selected from the group consisting of iron cations, zinc cations. Most preferably, the pro-oxidative cations are iron cations. In a preferred embodiment of the present invention the emulsion contains a substantial amount of pro-oxidative metal cations,
especially iron cation, e.g. at least 3 mg/1, preferably at least 5 mg/1, more preferably at least 10 mg/1 and most preferably at least 20 mg/1. Typically, the amount of pro-oxidative metal cations contained in the packaged emulsion does not exceed 130 mg/1. Preferably pro-oxidant metal cations are
present in a concentration that does not exceed 100 mg/1, more preferably does not exceed 60 mg/1, most preferably does not exceed 20 mg/1.
The term "vitamin C" as used herein encompasses ascorbic acid 20 as well as any edible salts or esters thereof. Preferably, the present product comprises an alkali metal salt of ascorbic acid, e.g. sodium ascorbate. The vitamin C concentration in the present emulsion preferably is at least 20 mg/1, more preferably at least 50 mg/1, even more preferably at least 100
mg/1 and most preferably at least 250 mg/1. The vitamin C concentration preferably does not exceed 1800 mg/1, most preferably it does not exceed 1500 mg/1.
In order to achieve high oxidation-stability it is advisable to employ a high molar ratio of vitamin C to pro-oxidative metal cations, especially iron cations. Preferably, said molar ratio exceeds 1:1, more preferably it exceeds 1.5:1 and most preferably it exceeds 2:1.

WO 2007/054195

PCT/EP2006/01014


The present emulsion typically contains at least 75 wt.% of water. More preferably, the present emulsion contains at least 80 wt. of water. The amount of water contained in the present 5 emulsion preferably does not exceed 95 wt.%.
An important advantage of the present invention resides in the fact that the present emulsion can be produced without the need of using equipment that is operated under an oxygen-free
atmosphere. As a result, the present emulsion, in particular shortly after manufacture, typically contains at leastO.l ppm of oxygen, preferably at least 0.2 ppm of oxygen. The amount of oxygen contained in the present emulsion preferably does not exceed 10 ppm. More preferably said amount does not exceed 5
ppm, most preferably it does not exceed 2 ppm. Due to direct contact between the emulsion components and air, not only oxygen, but also carbon dioxide and nitrogen will be introduced into the packaged emulsion. Usually, the present emulsion contains at least 0.3 mg/1 of nitrogen, preferably at least 1
mg/1 of nitrogen. Furthermore, the emulsion typically contains carbon dioxide and nitrogen in a weight ratio of at least 1:2500.
When the present packaged emulsion is produced in the presence 25 of air, the oil in the packaged emulsion usually contains a significant amount of oxidised polyunsaturated fatty acids in the form of peroxides. In a preferred embodiment the present emulsion is produced in the presence air, in which case the oil present in the packaged emulsion typically has a peroxide value 30 of at least 0.5.
Vitamin C is capable of preventing oxidative degradation in that it is oxidised even more rapidly than the polyunsaturated

WO 2007/054195

PCT/EP2006/010134


fatty acids and, unless it is oxidised to a very high degree, does not give rise to off-flavour development. When the present emulsion is produced without the use of an oxygen-free atmosphere, as is preferred, the oxygen present in the emulsion 5 will oxidise a significant fraction of the vitamin C present in the emulsion. Typically, at least 5%, preferably at least 10% of the vitamin C present in the emulsion is oxidised.
The benefits of the present invention are particularly pronounced in case the emulsion contains polyunsaturated fatty acids that are extremely sensitive to oxidation. Generally speaking, sensitivity of oxidation increases exponentially with the number of double bonds present in the fatty acid. According to a particularly preferred embodiment, the polyunsaturated fatty acids contain at least three double bonds. According to an even more preferred embodiment, the present emulsion contains at least 10 mg/1, preferably at least 50 mg/1 of co-3 fatty acids, especially of o>-3 fatty acids selected from the group consisting of DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid) and combinations thereof. Usually, the combined amount of DHA and EPA contained in the present emulsions does not exceed 3 g/1, preferably it does not exceed 1 g/1.
The present product may advantageously be used to provide an optimised balance of important nutrients. Accordingly, the present emulsion preferably contains
• 0.5-8 wt.% protein;
• 1-6 wt.% oil;
• 6-20 wt.% carbohydrates;
• up to 5 wt.% of optional other nutritional components.
Examples of other nutritional components that
UNILEUER PTENT DEPT EP20060101

advantageously be incorporated include: vitamins, phytosterols, polyphenols, flavonoids, carotenoids etc.
The present emulsion preferably— is a pourable liquid. Even more I 5 preferably, the emulsion is a thin liquid as evidenced by a viscosity in the range of 5-200 mPa.s at 10 s"1, preferably in the range of 5-100 mPa.s at 10 s-1. The viscosity of the emulsion is suitably determined by means of a Rheometer ®AR1000, using a shear rate sweep from 0.01 to 250 s"1 (in 510 10 s.) and a cone plate measuring system with a cone angle 2:0:38 (deg:min:sec), a cone diameter of 40 mm and a truncation of 54 microns. Preferably, the viscosity is measured at a temperature of 20 °C.
The oil comprised in the present emulsion preferably contains at least 50 wt.%, more preferably at least 80 wt.% of a highly unsaturated oil selected from the group consisting of marine oil (e.g. fish oil or algae oil), rapeseed oil, olive oil, soybean oil, sunflower oil, linseed oil, cashew nut oil, walnut
oil, peanut oil canola oil and combinations thereof. According to a particularly preferred embodiment, the present emulsion contains at least 0.01 wt.I of marine oil.
In order to ensure that the present emulsion is sufficiently stable against syneresis, flocculation and creaming, it is
preferred that the oil is present as dispersed droplets with a diameter D3/^ of 0.1-3 urn, preferably of 0.3-2 um. The D3,2 diameter (i.e. the surface weighted average diameter) is suitably determined by means of laser diffraction, using a 30 Helos ™ laser diffraction sensor (ex Sympatec GmbH) in
combination with a 632.8 nm laser. Measurements are conducted at 20 °C using a QUTXEL ™ wet dispenser ex Sympatec GmbH (at an optical concentration between 10 and 20%).

ceived at the EPO on Feb 07, 2008 11:50:12.
AMENDED SHEET

TOTAL P.1

WO 2007/054195S

PCT/EP2006/010134


In accordance with another preferred embodiment the present emulsion contains between 0.1 and 15 wt.%, more preferably between 1 and 10 wt.% of a starch component selected from the 5 group consisting of native starches, modified starches and combinations thereof. The incorporation of a starch component offers the advantage that it stabilises the emulsion and at the same time provides a digestible carbohydrate.
The present packaged emulsion does not oxidise significantly even when exposed to extreme storage conditions, such as several weeks at 40°C. According to a particularly preferred embodiment, the packaged emulsion can be stored for more than 8 weeks, even more preferably for at least 15 weeks at a
temperature of 40°C without developing an unacceptable off- flavour.
In order to guarantee adequate storage stability the present emulsion preferably is a sterile emulsion. The pH of the 20 emulsion preferably is within the range of 4-8. More
preferably, the emulsion has a pH between 5 and 7.5, mot preferably between 6.5 and 7.
The oxidation stability of the present packaged emulsion is 25 achieved without the need of using highly effective antioxidants such as BHA, BHT and TBHQ. Accordingly, in a preferred embodiment the emulsion does not contain an anti-oxidant selected from the group consisting of BHA, BHT and TBHQ.
Yet another aspect of the present invention relates to a method of preparing a packaged emulsion as defined herein before, said method comprising: • combining oil, pro-oxidative metal cation, vitamin C and

WO 2007/054195

PCT/EP2006/010134


water in a pre-emulsion;
• homogenising the pre-emulsion;
• sterilising the homogenised emulsion; and
• packaging the sterilised emulsion in a container that holds no headspace;
wherein the pre-emulsion contains at least 0.1 ppm of oxygen.
The invention is further illustrated by means of the following
examples.

EXAMPLE 1
29.9 kg of water was weighed and heated to 80°C in an open vessel. 2.88 kg of skimmed milk powder was pre-mixed with 0.1
kg of potassium phosphate and 40 g of mono/di-glycerides (HV-52 K Danisco). This mixture was dispersed in the hot water under high speed mixing and hydrated under proper mixing for 15 minutes. An oil blend containing 0.95% DHA was produced using Soybean oil and a DHA concentrate based on Algae oil ex
Nutrinova in a ratio of 97.8:2.2%. 1.06 kg of this oil mixture was added under high speed mixing and pre-emulsified by proper mixing for 15 minutes. 3.76 kg of maltodextrin DE20 and 0.2 kg of native starch was dispersed in this pre-emulsion
Vitamins/minerals and colouring ingredients (e.g. caramel) were mixed to a blend containing 5 g of Fe-fumarate and 37.2 g of vitamin C (As sodium ascorbate) . This blend was added to the pre-emulsion. Next, 1.6 kg of sugar was added to the pre-emulsion. Flavours were added to the pre-emulsion at the
desired level. The pH was checked and corrected whenever it was below < 6.7 using phosphate buffer. Final concentration of vitamin C equals 930 mg/kg and final concentration of 43 mg/kg Fe2+

WO 2007/054195

PCT/EP2006/010134


The product was homogenised at 175 - 250 bar and 65-70°C and thereafter UHT treated at 14 0°C - 4 sec. Thereafter the product was cooled to 25-30°C and filled aseptically in aluminum bags 5 without headspace.
The products were stored at 40°C and evaluated on taste. Below the taste evaluation results by an expert panel are presented (average over n=5)

Time (Storage temperature) Taste score (0-10)
1 day (7 °c) 6.3
4 weeks (40 °C) 6.9
2 months (4 0 °C) 6.5
3 months (4 0 °C) 6.6
After 2 months the vitamin C level analysed was 554 mg/kg. These results demonstrate that the packaged emulsion was extremely oxidation stable as it did not develop significant 15 off-flavour during prolonged storage under extreme conditions even though the product contained an appreciable amount of highly unstable polyunsaturated fatty acids. The observed reduction in vitamin C content indicates that vitamin C was preferentially oxidised during storage.

UNILEUER PATENT DEPT EP20060lb:
Claims
1. A packaged, oxidation-stable oil-in-water emulsion, said emulsion being a pourable liquid comprising:
• 0.1-10 wt.% of oil, said oil containing 0.3-80 g of polyunsaturated fatty acids per liter of emulsion;
• at least -3r2_0 mg/1 of pro oxidatative-mefea-l-iron cations;
• 10-2000 mg/1 of vitamin C; and
• up to 98 wt.% of water;
wherein the container comprising the emulsion holds no headspace and wherein the molar ratio of vitamin C to pro-oxidative metal cations exceeds 1:2, preferably exceeds 1: lj_ and wherein the emulsion contains at least 10 mg/1 of polyunsaturated fatty acids selected from the group consisting of docosahexenoic acid (DHA), eicosapentenoic acid (EPA) and combinations thereof.
2. Packaged emulsion according to claim 1, wherein the emulsion contains at least 0.1 ppm of oxygen.
3. Packaged emulsion according to claim 1 or 2, wherein the oil has a peroxide value of at least 0.2.
4. Packaged emulsion according to any one of the preceding
claims, wherein the emulsion contains at least 0.3 mg/1
nitrogen and contains carbon dioxide and nitrogen in a
weight ratio of at least 1:2500.
5. Packaged emulsion according to any one of the preceding claims, wherein at least 5% of the vitamin C is oxidised.
ceived at the EPO on Feb 07, 2008 11:50:12. AMENDED SHEET

07-02:2008 UNILEUER PATENT DEPT EP20060101:

6. Packaged emulsion according to any one of the preceding claims, wherein the pro-Oxidative metal cations are iron cations.
7. Packaged emulsion according to any one of the preceding claims, wherein the polyunsaturated fatty acids contain at least three double bonds.

8. Packaged emulsion according to any one of the preceding claims, wherein the emulsion contains at least 10 mg/1, preferably at least 50 mg/1 of polyunsaturated fatty acids selected from the group consisting of docosahexenoic acid (DHA), eicosapentenoic acid (EPA) and combinations thereof.
9. Packaged emulsion according to any one of the preceding claims, wherein the emulsion contains

• 0.5-8 wt.% protein;
• 1-6 wt.% oil;
• 6-20 wt.% carbohydrates;
• up to 5 wt.% of optional other nutritional components.
10. Packaged emulsion according to any one of the preceding
claims, said emulsion having a viscosity in the range of 5-
200 mPa.s at 10 s"1.
11. Packaged emulsion according to any one of the preceding
claims, wherein the oil contains at least 50 wt.% of highly
unsaturated oil selected from the group consisting of marine
oil, rapeseed oil, olive oil, soybean oil, sunflower oil,
linseed oil, cashew nut oil, walnut oil, peanut oil canola
oil and combinations thereof.
ceived at the EPO on Feb 07, 2008 11:50:12. AMENDED SHEET
07-02-2008 UNILEUER PATENT DEPT EP20060101:

12. Packaged emulsion according to any one of the preceding claims, wherein the oil is present as dispersed droplets with a diameter D3,2 of 0.1-3 urn, preferably of 0.3-2 urn.
13. Packaged emulsion according to any one of the preceding claims, wherein the emulsion contains between 0.1 and 15 wt.% of a starch component selected from the group consisting of native starches, modified starches and combinations thereof.
14. Packaged emulsion according to any one of the preceding claims, wherein the emulsion does not contain an antioxidant selected from the group consisting of BHA, BHT and TBHQ.
15. A method of preparing a packaged emulsion according to any one of the preceding claims, comprising:
• combining oil, pro-oxidative metal cation, vitamin C and water in a pre-emulsion;
• homogenising the pre-emulsion;
• sterilising the homogenised emulsion; and
• packaging the sterilised emulsion in a container that holds no headspace;
wherein the pre-emulsion contains at least 0.1 ppm of
oxygen.